Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
Terminated
Medicis Pharmaceutical Corporation
Phase 4
2011-09-01
This study will test if the use of DysportTM (abobotulinumtoxinA) improves wound healing and
scarring after Mohs surgery. Research in the laboratory as well as previous studies in humans
have shown improved wound healing and scarring with the use of a similar medication called
Botox.
Dysport may improve wound healing and scarring by relaxing facial muscles and therefore
minimizes the muscle tension and possibly the inflammation around the wound.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
